首页 > 市场调查报告书 > 医疗设备

疼痛

市场调查报告书

商品编码

1297767

全球疼痛管理设备市场 - 2023-2030年

Global Pain Management Devices Market - 2023-2030

出版日期: 2023年06月15日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球疼痛管理设备市场在2022年达到37亿美元，预计到2030年将见证有利可图的增长，达到63亿美元。在预测期间（2023-2030年），全球疼痛管理设备市场预计将呈现7.1%的复合增长率。

疼痛管理是医学科学的一门学科，有助于缓解慢性疼痛患者的痛苦。众所周知，急性疼痛有一个快速的开始作用，然而慢性疼痛可能会持续较长时间，有必要进行疼痛治疗。

由于疼痛管理方面的技术进步和大规模研发的升级，对护理点测试的需求增加，以及手术后疼痛的重新出现，全球疼痛管理设备市场正在大幅增长。

市场动态

对微创手术的需求不断增长，进一步提高了疼痛管理设备市场的增长。

在外科手术中使用的疼痛管理设备提高了病人的效果和满意度。微创手术中最常使用的一些疼痛管理技术包括病人控制的镇痛（PCA）泵、经皮神经电刺激（TENS）装置和周围神经阻滞。例如，在美国，医疗保险和医疗补助服务中心（CMS）制定了促进使用替代性疼痛管理方法的规则，以限制手术患者使用阿片类药物。

疼痛管理设备的可用性差

在一些低收入地区，疼痛治疗设备的可用性是有限的，限制了市场增长。根据世界卫生组织的统计，55亿人（占世界人口的80%以上）无法获得中度至重度疼痛的治疗。疼痛治疗的一些障碍包括对减少疼痛缺乏了解和态度，以及药物获取和使用方面的挑战，特别是阿片类药物。

COVID-19影响分析

疼痛管理设备市场受到COVID-19的严重影响，其中有许多因素是背后的原因，如对基于家庭的解决方案的需求增加：由于整个流行病的运动限制和对医疗设施的有限访问，人们更加重视基于家庭的疼痛治疗。这提高了对居家疼痛治疗产品的需求，如经皮神经电刺激（TENS）装置、热疗设备和便携式超声波机。

远程医疗和远程监控：这一流行病增加了对远程医疗和远程监测技术的使用。虚拟咨询和远程监控设备已经被病人用来在家里治疗慢性疼痛疾病。具有连接功能的疼痛治疗小工具越来越受欢迎，使病人能够与医疗专家交谈，并从远处接受帮助。

Market Overview

The Global Pain Management Devices Market reached US$ 3.7 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 6.3 billion by 2030. The global pain management devices market is expected to exhibit a CAGR of 7.1% during the forecast period (2023-2030).

Pain management is a discipline of medical science that aids in the relief of chronic pain sufferers' suffering. Acute pain is known to have a fast beginning of action, however chronic pain may linger for a longer period of time, necessitating pain treatment.

The global pain management devices market is growing significantly due to escalating technological advancement and massive research and development in pain management, increasing demand for point-of-care testing, and the reappearance of pain after surgery.

Market Dynamics

The Growing Demand for Minimally Invasive Surgeries is Further Increasing the Pain Management Devices Market Growth

Pain management devices used in surgical operations increase patient results and satisfaction. Some of the most often utilized pain management technologies in minimally invasive operations include patient-controlled analgesia (PCA) pumps, transcutaneous electrical nerve stimulation (TENS) units, and peripheral nerve blocks. For instance, In United States, the Centers for Medicare and Medicaid Services (CMS) incorporated rules to promote the use of alternative pain management methods in order to limit the use of opioids for patients having surgery.

Poor Availability of Pain Management Devices

The availability of pain treatment devices is limited in several low-income locations, limiting market growth. According to WHO, 5.5 billion people (more than 80% of the world population) do not have access to moderate to severe pain remedies.2 The majority of these folks are from low- and middle-income nations. Some hurdles to pain treatment include a lack of understanding and attitudes about pain reduction, as well as challenges with drug access and use, particularly opioids.

COVID-19 Impact Analysis

Pain management devices market had severe impact by COVID-19 where numerous factors are the reason behind like Increased demand for home-based solutions: Because of movement constraints and limited access to healthcare facilities throughout the epidemic, there has been a greater emphasis on home-based pain treatment. This has raised demand for at-home pain treatment products such as transcutaneous electrical nerve stimulation (TENS) units, thermal therapy devices, and portable ultrasound machines.

Telemedicine and remote monitoring: The epidemic increased the use of telemedicine and remote monitoring technology. Virtual consultations and remote monitoring equipment have been used by patients to treat chronic pain disorders from home. Pain treatment gadgets with connection features have grown more popular, allowing patients to speak with healthcare specialists and receive help from a distance.

Segment Analysis

The global pain management devices market is segmented based on product type, application

The Musculoskeletal Pain Application Segment will be Dominated By Market Players During the Forecast Period.

During the forecast period, the musculoskeletal pain category is expected to retain a sizable proportion of 42.3%. The expanding ageing population and the increasing adoption of sedentary lifestyles are the primary causes of the rise in musculoskeletal discomfort among people. Patients and healthcare professionals are using a variety of solutions, including pain management devices, to address musculoskeletal pain, leading in segmental increase.

Geographical Analysis

North America is the Dominating Region During the Forecast Period accounting for around 39.8% of the Total Market Share

North America has dominated the market for pain treatment devices due to a huge patient pool, rising healthcare expenditure, and increased government financing and efforts.The market in the region is expanding rapidly, owing mostly to an ageing population, a drastic lifestyle connected with sickness, and neurological diseases.

For example, in 2021, an estimated 20.9% of U.S. adults (51.6 million people) had chronic pain, and 6.9% (17.1 million people) had high-impact chronic pain (i.e., chronic pain that limits daily activities significantly), with a higher prevalence among non-Hispanic American Indian or Alaska Native adults, adults who identified as bisexual, and adults who were divorced or separated.

Competitive Landscape

The major global players include: Stim Wave LLC, Baxter International, Inc., Boston Scientific Corp., ICU Medical Inc, Johnson & Johnson Company, DJO Global LLC, Liva Nova, Medtronic Plc, Smiths Medical, Abbott, and Stryker Corp.

Why Purchase the Report?

To visualize the global pain management devices market segmentation based on the product type, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global pain management devices market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global pain management devices market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increase in prevalence of pulmonary artery hypertension
- 4.1.2. Restraints
  - 4.1.2.1. Side effects of the drug used for treating Pain Management Devices
- 4.1.3. Opportunity
  - 4.1.3.1. Rapidly growing generic drug market
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion s of COVID-19

7. By Product Type

7.1 Stimulated Neuromodulator Devices
7.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
7.3 Spinal Cord Stimulation (SCS) Devices
7.4 Ablation Devices
- 7.1.1. Cryoablation Devices
- 7.1.2. Radiofrequency
7.5 Analgesia Infusion Pumps
- 7.1.3. Intrathecal Infusion Pumps
- 7.1.4. External Infusion Pumps
7.6 Others

8. By Application

8.1. Cancer Pain
8.2. Musculoskeletal Pain
8.3. Migraine
8.4. Neuropathic Pain
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. The U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. The UK
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Spain
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country